利拉鲁肽
赛马鲁肽
医学
内分泌学
糖尿病
2型糖尿病
作者
Georgios Schoretsanitis,Stefan Weiler,Corrado Barbui,Emanuel Raschi,Chiara Gastaldon
出处
期刊：JAMA network open
[American Medical Association]
日期：2024-08-20
卷期号：7 (8): e2423385-e2423385
标识
DOI：10.1001/jamanetworkopen.2024.23385
摘要
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained use primarily due to their weight-reduction effects, although a regulatory review was undertaken for potential suicidality concern.
科研通智能强力驱动
Strongly Powered by AbleSci AI
pluto
昏睡的蟠桃
cdercder
qiao
jenningseastera
Oracle
bc
不倦
HEIKU
小飞飞
iNk
笨笨芯
平常的毛豆
HEAUBOOK
pcr163
今天只做一件事
研友_Y59785
善良的剑通
科研小民工
wy.he
皖公网安备34019202002308
